Navigation Links
Afinitor (Breast Cancer) - Analysis and Forecasts to 2020
Date:10/20/2011

NEW YORK, Oct. 20, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Afinitor (Breast Cancer) – Analysis and Forecasts to 2020

http://www.reportlinker.com/p0657207/Afinitor-Breast-Cancer-–-Analysis-and-Forecasts-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

Afinitor (Breast Cancer) – Analysis and Forecasts to 2020

Summary

GlobalData's pharmaceuticals report, "Afinitor (Breast Cancer) – Analysis and Forecasts to 2020" provides Afinitor sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Breast Cancer market. This report is built using data and information sourced from GlobalData's proprietary databases, primary and secondary research using Company's corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.

Note: This is a on-demand report and will be delivered within 7 business days (excluding weekends) of the purchase.

Scope

- Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)

- Analysis and review of Afinitor including sales data

- Qualitative and quantitative assessment of market space

- Analysis of the trends, drivers and restra
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Novartis Drug Afinitor® Effective in Patients With Non-Cancerous Kidney Tumors Associated With TSC in Phase III Trial
2. Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
3. FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
4. Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
5. Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin
6. Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
7. Study in NEJM Shows Novartis Drug Afinitor® Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis
8. FDA Approves New Indication for Afinitor
9. VIDEO from thenewsmarket.com and Novartis: Novartis drug Afinitor® Approved by FDA as First Medication for Children and Adults With a Benign Brain Tumor Associated With Tuberous Sclerosis
10. Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors
11. Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013 Assured Pharmacy, ... providing prescription medications to sufferers of chronic pain, announced ... recognized, national investor relations firm, to raise its visibility ... "Over the past year, we have proven our ... recently announced plans to open two additional new pharmacies ...
(Date:5/22/2013)... VANCOUVER, British Columbia , May 22, 2013 /PRNewswire/ ... in the development of novel therapeutics to target mechanisms of ... its investigational compounds, custirsen and OGX-427, will be presented as ... Meeting of the American Society of Clinical Oncology (ASCO) in ... June 4. Despite the availability of drugs ...
(Date:5/22/2013)... , May 22, 2013 WomanCare Global ... with an extensive training initiative attended by ... http://photos.prnewswire.com/prnh/20130522/DC18844 ) (Logo: http://photos.prnewswire.com/prnh/20101018/DC83896LOGO ) ... is a highly effective subdermal implant composed of ... mg levonorgestrel (a synthetic form of the hormone ...
Breaking Medicine Technology:Assured Pharmacy Hires Hayden IR 2Assured Pharmacy Hires Hayden IR 3OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 2OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 3OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 4OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 5WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile 2
... evaluate erectile ... ED patients with dyslipidemia, CHICAGO, Dec. 10 ... erectile function in,erectile dysfunction (ED) patients with dyslipidemia show ... the ability,of men with ED and dyslipidemia to achieve ...
... -Patients treated with Lovenox(R) (enoxaparin sodium injection) were also ... to be readmitted to hospital within 90 days-, ... of a study that demonstrated total hospital,direct medical costs ... when they were treated with the use of low-molecular ...
Cached Medicine Technology:New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol 2New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol 3New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol 4New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol 5Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 2Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 3Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 4Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 5
(Date:5/21/2013)... The University of Colorado’s Anschutz Health and ... to help Coloradans make healthier choices when they eat ... called HEALTHY DINING IN COLORADO. More than 40 ... Colorado. Restaurants will offer a selection of dietitian verified ... vegetables, fruits, whole grains and unsaturated fats. , “Families ...
(Date:5/21/2013)... CO (PRWEB) May 22, 2013 Spring ... for better nutrition--from farmers' markets filled with whole foods ... make the most of the season the nutrition experts ... healthier lifestyle not to miss. , 1. Eating Locally, ... that invites shoppers to linger and explore, spring is ...
(Date:5/21/2013)... May 22, 2013 Swimsuit season is almost ... Whisperer ® products has begun with a 35% discount. , ... estrogen. Many women get the dreaded cellulite even if they ... the skin where they have been stored as toxic lymph ... no easy fixes, a specific program that works to dissolve ...
(Date:5/21/2013)... Illinois (PRWEB) May 21, 2013 Heritage ... community], a BMA affordable assisted living community, is hosting a ... of Arthritis at 2 p.m. on Tuesday, May 28. , ... Dwight, Illinois, serves older adults of all incomes, including those ... , The Arthritis program is open to the public. ...
(Date:5/21/2013)... 2013 Feed additives have now become ... value chain. Most of the feed additives are used ... liquids, and powders. There are variety of feed additives ... depending upon the type of animal and feed. Nutritional ... provide essential nutrition to the animal in order to ...
Breaking Medicine News(10 mins):Health News:Colorado Takes a Huge Step toward Transforming the Family Dining Experience 2Health News:Colorado Takes a Huge Step toward Transforming the Family Dining Experience 3Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 2Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 3Health News:Diminish Cellulite for Swimsuit Season; Sublime Beauty Introduces Cellulite Whisperer® Products in the "Get Ready for Summer Sale" 2Health News:Heritage Woods of Dwight Affordable Assisted Living to Host Informational Program on the Do's and Don'ts of Arthritis 2Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 2Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 3Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 4
... Hydroxycut products, consumers who have suffered injuries from using Hydroxycut are ... attorney to determine if he/she is eligible for compensation. Lawinfo provides ... ... San Diego, CA (PRWEB) May 26, 2009 -- For ...
... held consulting company, announced today its partnership ... automated software solutions. Veracord,s comprehensive IT expertise ... product delivery to quality software IT implementation ... clients in the Life Sciences industry a ...
... a Finalist in the 2009 American Business Awards for its Interactive ... ... May 26, 2009 -- The American Business Awards are the nation,s ... eligible to submit entries to the ABAs - public and private, ...
... People Save More Money into Health Savings Accounts - A Smart and Simple ... ... Healthy Rebates, Inc. today announced the launch of My HSA Rewards, a web ... to help save more money for health care. , , ,The program, ...
... (Aircraft),the UK medical devices company, today announces that ... market with the acquisition of,Morpheus Medical (Morpheus), the ... Morpheus is a leading developer of patient ... Morpheus, lead product, the IoC-View,is designed to measure ...
... and simple way to diagnose a serious problem facing ... Ph.D., M.P.H., MetroHealth System pediatrician, internist, and chief medical ... Medicine researcher and faculty member. Nearly 75% of ... in children and adolescents go undiagnosed. These troubling ...
Cached Medicine News:Health News:LawInfo Provides Access to Qualified Hydroxycut Litigation Attorneys Nationwide 2Health News:Veracord and Parasoft Partner to Improve Compliance and Reduce Cost 2Health News:Veracord and Parasoft Partner to Improve Compliance and Reduce Cost 3Health News:iHealthSpot, Inc Named as Finalist in American Business Awards(sm) 7th Annual Stevie Awards will be Presented on June 22 in New York City 2Health News:iHealthSpot, Inc Named as Finalist in American Business Awards(sm) 7th Annual Stevie Awards will be Presented on June 22 in New York City 3Health News:Healthy Rebates, Inc. Announces the Launch of My HSA Rewards 2Health News:Aircraft Medical Enters Anaesthesia Monitoring Market With Acquisition of Morpheus Medical, S.L. 2Health News:Pediatrician creates easier way to identify kids' high BP 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: